Navigation Links
AAIPharma Expands Laboratory Service Offerings and Capabilities in its Technology Center
Date:1/22/2013

WILMINGTON, N.C., Jan. 22, 2013 /PRNewswire/ -- AAIPharma Services Corp. ("AAIPharma"), a leading provider of pharmaceutical product development services, announced today the expansion of laboratory service offerings, capabilities and instrumentation in its state-of-the-art laboratory Technology Center in Wilmington, N.C. 

(Logo:  http://photos.prnewswire.com/prnh/20121207/MM26042LOGO)

Following the company's opening of its Technology Center in May, 2012, AAIPharma has continued investing in its service offerings and acquired additional instrumentation to support its analytical and biopharmaceutical development laboratories.    

"AAIPharma specializes in comprehensive service offerings and offers the latest in instrumentation for our clients," said Patrick Walsh , chief executive officer of AAIPharma. "Since its grand opening, the Technology Center has been recognized for its modern, efficient operations and has exceeded client expectations as a world class laboratory."

AAIPharma continues to focus on serving clients' needs and has added new ICP-MS, GC-MS, LC-MS, UPLC and HPLC systems to its expansive list of instrumentation and capabilities to meet growing market demands. A Malvern™ Mastersizer 3000 particle size analyzer was added to support preformulation and material testing services. 

The company expanded its biopharmaceutical development services by adding a ProteinSimple MFI™5200 micro-flow imaging system, a Wyatt Dawn ® Heleos®II multi-angle laser light scattering (MALS) detector and a Wyatt DynaPro NanoStar dynamic light scattering (DLS) detector to support aggregate and particulate testing services.  A ProteinSimple iCE3 capillary IEF was added to further support protein analyses.

AAIPharma also expanded its extractable and leachable (E&L) testing services to evaluate and qualify the materials used in the manufacturing process and final product configuration. AAIPharma's subject matter experts already provide exceptional E&L testing services, and new capabilities include a Foss Soxtec™ 2050 automated extraction system to enable reproducible and robust methodologies.

About AAIPharma Services Corp. 

AAIPharma Services Corp. is a leading provider of contract services that support all phases of drug development. The company's wide array of capabilities includes analytical chemistry, formulation development, material testing services, microbiology, clinical and commercial contract manufacturing, pharmaceutical packaging, and stability services. Serving more than 600 clients around the globe and headquartered in Wilmington, N.C., AAIPharma is a portfolio company of Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care.

For more information on the company, visit www.aaipharma.com.

Related Links:

AAIPharma's Analytical Development Capabilities
http://aaipharma.com/development/analytical-development

AAIPharma's Biotechnology, Biopharmaceutical and Structural Chemistry Capabilities
http://aaipharma.com/development/analytical-chemistry/biotechnology-services

AAIPharma News and Events:
http://aaipharma.com/news-and-events/

AAIPharma Home Page:
http://aaipharma.com


'/>"/>
SOURCE AAIPharma Services Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AAIPharma Appoints Director Of Analytical Chemistry
2. AAIPharma Appoints Senior Director of Biopharmaceutical Development
3. AAIPharma Announces Promotion Of Dean Shirazi To EVP Of Analytical Laboratories
4. As Smartphone Usage Expands, Survey Says Nurses and Nursing Students Want Mobile Access to Credible Drug Data
5. BioSurplus Expands, Debuts New 8000 Square Foot Warehouse and Service Facility
6. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
7. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
8. S1 Biopharma Expands Focus to Include Male Sexual Health
9. PRA Expands Operations in Europe
10. USANA Health Sciences Expands Award-Winning Research and Development Team
11. Particle Sciences Expands its cGMP Capabilities with the Addition of Thin Films
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Research and Markets has announced ... Market Prospects: Addressing Production Complexities Through Risk Management and ... ... Pipeline and Market Prospects: Overcoming Production Complexities Through Risk ... of the current trends in the global biosimilars market, ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ... their offering. ... for drug delivery technologies will rise from USD 20 Billion in ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... 25, 2017 , ... A recent report from the Wisconsin ... the 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools ... in student test score performance, the report’s limited analyses fail to provide answers ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... ... Chaudhary, MD is committed to providing the highest quality of spine care to all his ... with all my patients to alleviate possible future issues. I am pleased to have you ... and my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary ...
(Date:4/25/2017)... ... 25, 2017 , ... Vetoquinol USA® , a world-class ... part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in ... immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of ...
(Date:4/24/2017)... Nashville, TN (PRWEB) , ... April 24, 2017 , ... ... electrifying fans and transforming the quarterback position. The former overall number one pick in ... his professional football career. He holds the record for the most career rushing yards ...
Breaking Medicine News(10 mins):